Clinical Trial

Valproate Versus Propranolol in Migraine

Unknown Phase 4
View on ClinicalTrials.gov →
Summary
Investigators aim to compare the effect of valproate versus propranolol in migraine by assessing the absolute reduction in MMD in each group and the percentage of patients who achieved ≥ 50% reduction in the monthly headache days frequency compared to the baseline frequency.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06485726
Lead Sponsor Kafrelsheikh University
Conditions Migraine Disorders
Enrollment 600 participants
Start Date 2023-01-23
Primary Completion 2024-07-01 (estimated)
Study Completion 2024-07-05 (estimated)
Updated on ClinicalTrials.gov 2024-07-03